Netsertive, a digital marketing technology company enabling brands and their local retail networks to execute turnkey digital marketing at scale, today announced that client La-Z-Boy supported their local store network during a key promotional event using its MarketWise solution.
The Board of Directors of Continuity, a leading provider of compliance management and regulatory technology, today announced that Howard Pitkin, the former Commissioner of Banking for the State of Connecticut, has been elected to the company’s board of directors.
Velocity maximizes digital marketing results for enterprise brands at a local level.
OrthAlign, Inc. Announces FDA Clearance for Direct Anterior Approach HipAlign®, the world’s first and only handheld technology providing cup placement, leg length, and offset accuracy data for DAA THAs
Sales and Marketing Technology Leader Set to Capitalize on 2016 Momentum.
Indianapolis Medical device maker NICO Corporation today announced the enrollment of the first patient in the ENRICH (Early MiNimally-invasive Removal of ICH) randomized clinical trial.
Blakely Murphy is recognized by NICO Corporation as the first patient in the world who can compare conventional brain surgery with a procedure using BrainPath technology.
“The River Cities team has been insightful and supportive throughout the challenges of launching a new business and the subsequent rapid growth of our company. They understand the key elements of successful strategy, collaboration and the art of getting things done. River Cities is an extremely valuable partner to our company,” says Mark Gilreath, CEO, EndoChoice.
Veran Medical Technologies today announced the closing of a $31 million debt and equity financing. The debt financing is provided by Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and the equity financing was completed by existing investors Versant Ventures and River Cities Capital Funds.
River Cities Capital Funds has announced the sale of MedPlast, Inc., a River Cities Fund IV portfolio company, to Water Street Healthcare Partners and JLL Partners.